BARDA BAA (through
Supports teams developing countermeasure technologies for CBRN, diagnostics, and readiness-focused therapeutics through BARDA BAA.
The BARDA Broad Agency Announcement (BAA-23-100-SOL-00004) is a multi-year, rolling solicitation issued by the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services. The BAA funds research and development of medical countermeasures (MCMs) against chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infect…
Medical countermeasure research and development across twelve threat areas including CBRN vaccines, antivirals, antimicrobials, diagnostics, radiological and chemical MCMs, burn and blast injury treatments, and flexible therapeutic platforms.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline